1型糖尿病起病时胰岛自身免疫证据微弱者的遗传决定因素
这项试点研究对142例疑似1型糖尿病起病者按自身抗体状态分组,用1型糖尿病遗传风险评分(GRS)和超过200个糖尿病相关基因的二代测序(NGS)筛查单基因糖尿病。自身抗体阴性者GRS显著低于单个及多个自身抗体阳性者;41例抗体阴性者中15例(36.6%)检出MODY或单基因糖尿病基因的致病性4/5类变异,26例单个抗体阳性者中2例(7.7%)检出。作者认为无抗体或单个抗体合并低GRS可能提示单基因糖尿病,NGS可能提高诊断准确性。
要点
- 抗体阴性者1型糖尿病GRS显著低于单个及多个自身抗体阳性者。
- 41例抗体阴性者中15例(36.6%)检出致病性4/5类变异。
- 26例单个抗体阳性者中2例(7.7%)检出致病性4/5类变异,60例多个抗体阳性者中未检出。
核心结论
- 无胰岛自身抗体或仅单个自身抗体合并低1型糖尿病GRS可能提示单基因糖尿病,使用NGS可能提高诊断准确性(作者结论)。
研究设计与样本
- 试点研究,对142例疑似1型糖尿病患者进行遗传筛查,其中起病时抗体阴性42例、单个抗体阳性27例、多个抗体阳性73例。
- 对41例抗体阴性、26例单个抗体阳性和60例多个抗体阳性者,用涵盖200余个糖尿病相关基因的分析流程行二代测序(NGS)。
主要发现
- 1型糖尿病GRS在抗体阴性者中显著低于单个抗体阳性和多个抗体阳性者。
- 致病性4/5类MODY或单基因糖尿病基因变异见于15/41(36.6%)抗体阴性者,意义未明的3类变异见于17/41(41.5%)。
- 诊断时残余C肽水平在有突变者中高于无致病性变异者。
- 意义未明的3类变异见于11/26(42.3%)单个抗体阳性者,致病性4/5类变异见于2/26(7.7%)单个抗体阳性者。
- 多个抗体阳性者中未检出致病性4/5类变异,意义未明的3类变异见于19/60(31.7%);三组中均有若干患者携带一个以上3类变异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Islet autoantibodies (AAbs) are detected in >90% of individuals with clinically suspected type 1 diabetes at disease onset. A single AAb, sometimes at low titre, is often detected in some individuals, making their diagnosis uncertain. Type 1 diabetes genetic risk scores (GRS) are a useful tool for discriminating polygenic autoimmune type 1 diabetes from other types of diabetes, particularly the monogenic forms, but testing is not routinely performed in the clinic. Here, we used a type 1 diabetes GRS to screen for monogenic diabetes in individuals with weak evidence of autoimmunity, i.e. with a single AAb at disease onset. METHODS: In a pilot study, we genetically screened 142 individuals with suspected type 1 diabetes, 42 of whom were AAb-negative, 27 of whom had a single AAb (single AAb-positive) and 73 of whom had multiple AAbs (multiple AAb-positive) at disease onset. Next-generation sequencing (NGS) was performed in 41 AAb-negative participants, 26 single AAb-positive participants and 60 multiple AAb-positive participants using an analysis pipeline of more than 200 diabetes-associated genes. RESULTS: The type 1 diabetes GRS was significantly lower in AAb-negative individuals than in those with a single and multiple AAbs. Pathogenetic class 4/5 variants in MODY or monogenic diabetes genes were identified in 15/41 (36.6%) AAb-negative individuals, while class 3 variants of unknown significance were identified in 17/41 (41.5%). Residual C-peptide levels at diagnosis were higher in individuals with mutations compared to those without pathogenetic variants. Class 3 variants of unknown significance were found in 11/26 (42.3%) single AAb-positive individuals, and pathogenetic class 4/5 variants were present in 2/26 (7.7%) single AAb-positive individuals. No pathogenetic class 4/5 variants were identified in multiple AAb-positive individuals, but class 3 variants of unknown significance were identified in 19/60 (31.7%) patients. Several patients across the three groups had more than one class 3 variant. CONCLUSIONS/INTERPRETATION: These findings provide insights into the genetic makeup of patients who show weak evidence of autoimmunity at disease onset. Absence of islet AAbs or the presence of a single AAb together with a low type 1 diabetes GRS may be indicative of a monogenic form of diabetes, and use of NGS may improve the accuracy of diagnosis.
引用
- Carrera P, Marzinotto I, Bonfanti R, et al. Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset. Diabetologia. 2023. PMID: 36692510. doi:10.1007/s00125-022-05865-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。